$1.39 +0.10 (%) Alexza Pharmaceuticals Inc - NASDAQ

Dec. 18, 2014 | 12:39 PM

Partner Headlines

  1. Alexza Amends Autoliv Agreement for Heat Packages Used in ADASUVE

    Benzinga | Dec. 16, 2014 | 16:06PM EST
  2. Morning Market Movers

    Benzinga | Oct. 27, 2014 | 09:55AM EST
  3. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 12, 2014 | 10:07AM EST
  4. Benzinga's Top Downgrades

    Benzinga | Aug. 8, 2014 | 09:04AM EST
  5. Roth Capital Downgrades Alexza Pharmaceuticals To Neutral

    Benzinga | Aug. 8, 2014 | 08:02AM EST
  6. Wrong Marketing Lesson by Big Pharma

    GuruFocus | May. 3, 2014 | 20:20PM EST
  7. Weekly CEO Buys Highlight: RCL, PSXP, ALXA, PAY, HAFC

    GuruFocus | Aug. 5, 2013 | 12:31PM EST
  8. Royal Caribbean and Four Others Report $100 Thousand CEO Buys

    GuruFocus | Jul. 31, 2013 | 12:29PM EST
  9. Alexza Pharma Reports European Launch of ADASUVE

    Benzinga | Jul. 30, 2013 | 09:01AM EST
  10. President and CEO of Alexza Pharmaceuticals Inc. Thomas Braxton King Bought 40,000 Shares

    GuruFocus | Jul. 29, 2013 | 20:22PM EST
  11. Weekly CEO Buys Highlight: NYLD, ALXA, DOC, NTWK, SNV

    GuruFocus | Jul. 29, 2013 | 12:49PM EST
  12. UPDATE: Piper Jaffray Initiates Coverage on Alexza Pharmaceuticals to Neutral Rating, $5 PT

    Benzinga | Jan. 4, 2013 | 02:59AM EST
  13. Alexza Pharma Says CHMP Gives Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE

    Benzinga | Dec. 14, 2012 | 01:17AM EST
  14. Benzinga's Top Pre-Market Gainers

    Benzinga | Dec. 4, 2012 | 01:12AM EST
  15. Benzinga's Top Initiations

    Benzinga | Dec. 4, 2012 | 00:40AM EST
  16. Alexza Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 6, 2012 | 11:37AM EST
  17. Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO and Sec Mark K Oki sells 10,000 Shares

    GuruFocus | Aug. 30, 2012 | 11:00AM EST
  18. Alexza Pharmaceuticals Inc. (ALXA) Pres & CEO Thomas Braxton King sells 10,000 Shares

    GuruFocus | Aug. 30, 2012 | 11:00AM EST
  19. Health Care Sector Wrap

    FoxBusiness | Aug. 28, 2012 | 10:43AM EST
  20. Benzinga's Top Pre-Market Gainers

    Benzinga | Aug. 22, 2012 | 02:03AM EST
  21. Alexza Pharmaceuticals Receives EU Certificate of GMP Compliance for its ADASUVE™ Manufacturing Facility

    Benzinga | Aug. 21, 2012 | 12:40PM EST
  22. Aetna, QIHOO 360 Technology Included in Stocks Up on High Volume Monday

    FoxBusiness | Aug. 20, 2012 | 06:33AM EST
  23. Benzinga's Microcap Movers for Monday August 13, 2012

    Benzinga | Aug. 13, 2012 | 13:54PM EST
  24. Alexza Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 8, 2012 | 13:35PM EST
  25. From EArlier: Alexza Announces Adasuve PDUFA Goal Date of December 21, 2012

    Benzinga | Jul. 6, 2012 | 01:53AM EST
  26. Alexza Announces Adasuve PDUFA Goal Date of December 21, 2012

    Benzinga | Jul. 5, 2012 | 12:13PM EST
  27. Teva Pharmaceutical Industries, Constellation Brands Among Stocks Up on High Volume Monday

    FoxBusiness | Jun. 25, 2012 | 06:33AM EST
  28. Morning Market Movers

    Benzinga | Jun. 25, 2012 | 03:46AM EST
  29. Alexza Pharmaceuticals up 38% on Resubmission of ADASUVE NDA

    Benzinga | Jun. 22, 2012 | 08:18AM EST
  30. Mid-Day Market Movers

    Benzinga | Jun. 22, 2012 | 06:01AM EST
  31. Alexza Pharmaceuticals Inc. (ALXA) Pres & CEO Thomas Braxton King sells 65,516 Shares

    GuruFocus | Jun. 8, 2012 | 13:21PM EST
  32. Apricus Bioscience, Quepasa Corporation Among Stocks setting 52-Week Lows Wednesday

    FoxBusiness | Jun. 6, 2012 | 06:32AM EST
  33. Option Alert: Alexza Pharmaceuticals June 1/September 1 Call Spread; Block Trade: 2X 5,000 Contracts, Currently $0.43

    Benzinga | May. 14, 2012 | 05:56AM EST
  34. Benzinga's Microcap Movers for Friday May 4, 2012

    Benzinga | May. 5, 2012 | 06:12AM EST
  35. Alexza Receives Complete Response Letter for Adasuve NDA

    Benzinga | May. 3, 2012 | 11:32AM EST
  36. Alexza and Grupo Ferrer Amend Adasuve Partnership Alexza and Grupo Ferrer Amend Adasuve Partnership; Ferrer to Purchase 2.42M Shares of Alexza Common Stock for $1.24 per Share

    Benzinga | Mar. 7, 2012 | 09:31AM EST
  37. Notable Call Options Activity in Alexza Pharmaceuticals

    Benzinga | Jan. 3, 2012 | 08:23AM EST
  38. Microcap Movers for Thursday December 22, 2011

    Benzinga | Dec. 22, 2011 | 12:43PM EST
  39. Notable Call Options Activity in Alexza Pharmaceuticals

    Benzinga | Dec. 22, 2011 | 03:17AM EST
  40. Notable Call Options Activity in Alexza Pharmaceuticals

    Benzinga | Dec. 21, 2011 | 08:38AM EST
  41. Stocks Seek Direction in Early Trading

    MarketIntelligenceCenter | Dec. 19, 2011 | 10:48AM EST
  42. From Over the Weekend, Alexza Retains Lazard to Explore Strategic Options

    Benzinga | Dec. 19, 2011 | 00:39AM EST
  43. Microcap Movers for Tuesday December 13, 2011

    Benzinga | Dec. 13, 2011 | 11:40AM EST
  44. Investors Agitated by Alexza Drug Prospects, Buy Shares Anyway

    Benzinga | Dec. 13, 2011 | 03:03AM EST
  45. Microcap Movers for Monday December 12, 2011

    Benzinga | Dec. 12, 2011 | 10:43AM EST
  46. TheStreet's Analyst Adam Feuerstein States FDA Grim on Safety of Alexza Pharmaceuticals' ADASUVE Drug

    Benzinga | Dec. 12, 2011 | 04:14AM EST
  47. Microcap Movers for Friday December 9, 2011

    Benzinga | Dec. 9, 2011 | 11:15AM EST
  48. Highs & Lows: Alexza Pharmaceuticals and Madison Square Garden

    SchaeffersResearch | Dec. 8, 2011 | 14:19PM EST
  49. Notable Call Options Activity in Alexza Pharmaceuticals

    Benzinga | Dec. 8, 2011 | 07:05AM EST
  50. Zacks Downgrades Alexza Pharmaceuticals to Neutral

    Benzinga | Dec. 8, 2011 | 04:26AM EST
Trading Center